Synergistic enantioseparation system for racemate amlodipine based on a novel nanomaterial synthesized by chiral molecularly imprinted polymer and chiral metal–organic framework in capillary electrochromatography
Microchimica Acta · 2025
DOI: 10.1007/s00604-025-07242-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Chunyan Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing, 210009, PR China. Hauptthemen laut MEDLINE: Amlodipine, Capillary Electrochromatography, Metal-Organic Frameworks, Molecularly Imprinted Polymers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
A capillary coating column was prepared for capillary electrochromatography (CEC) using a novel nanomaterial synthesized by chiral metal-organic frameworks (CMOFs) (Co2(L-Trp)(INT)2(H2O)2(ClO4) and chiral molecularly imprinted polymers (CMIPs) as the stationary phase for enantioseparation of amlodipine. The rigid skeleton of CMOFs can be used as a support to reduce the deformation and collapse of CMIPs pores, the high specific surface area of CMOFs can increase the loading of molecular imprinting, while the viscosity of CMIPs improves the stability of stationary phases connected to the inner wall of capillaries. Compared with the capillary-coated columns with CMOFs and CMIPs as stationary phases alone, the novel capillary-coated columns utilizing the synergistic effect of CMIP@CMOF stationary phases showed a greatly improved chiral recognition (resolution: 0/0 → 5.79). The new nanomaterials synthesized by CMOFs and CMIPs as the stationary phase of CEC chiral resolution system show broad application prospects and potentials in the field of chiral drug/compound separation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing, 210009, PR China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China.
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, PR China. xiaoqili8619@163.com.
- Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA, 90095, USA. shuaijingdu@ucla.edu.
- Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing, 210009, PR China. du_yingxiang@126.com.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China. du_yingxiang@126.com.
Förderung
- Project of National Natural Science Foundation of China
Zitieren
APA
Guo, C., Miao, P., Yan, Y., Li, X., Du, S., & Du, Y. (2025). Synergistic enantioseparation system for racemate amlodipine based on a novel nanomaterial synthesized by chiral molecularly imprinted polymer and chiral metal–organic framework in capillary electrochromatography. Microchimica Acta. https://doi.org/10.1007/s00604-025-07242-6
Vancouver
Guo C, Miao P, Yan Y, Li X, Du S, Du Y. Synergistic enantioseparation system for racemate amlodipine based on a novel nanomaterial synthesized by chiral molecularly imprinted polymer and chiral metal–organic framework in capillary electrochromatography. Microchimica Acta. 2025. doi:10.1007/s00604-025-07242-6
BibTeX
@article{Guo2025,
author = {Guo, Chunyan and Miao, Pandeng and Yan, Yifan and Li, Xiaoqi and Du, Shuaijing and Du, Yingxiang},
title = {Synergistic enantioseparation system for racemate amlodipine based on a novel nanomaterial synthesized by chiral molecularly imprinted polymer and chiral metal–organic framework in capillary electrochromatography},
journal = {Microchimica Acta},
year = {2025},
doi = {10.1007/s00604-025-07242-6}
}
EUVIMED